Mylan NV Ord Shs (MYL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | MYL | RDY | BBIO | ||
Company | Mylan NV Ord Shs | Dr. Reddy's Laboratories Ltd ADR | Bridgebio Pharma Inc | ||
Price Information | |||||
Exchange | NASDAQ | NYSE | NASDAQ | ||
Open | 15.64 | 74.83 | 25.12 | ||
High | 16.15 | 75.22 | 25.64 | ||
Low | 15.34 | 74.30 | 25.01 | ||
Last | 15.86 | 74.42 | 25.47 | ||
Change | +0.31 | -0.13 | +0.59 | ||
% Change | +1.96% | -0.17% | +2.37% | ||
Volume | 26,574,100 | 230,707 | 1,161,600 | ||
20-Day Average Volume | 8,612,350 | 187,280 | 1,563,005 | ||
Previous Close | 15.55 | 74.55 | 24.88 | ||
Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 15.15 | 72.57 | 26.47 | ||
20-Day Raw Stochastic | 86.27% | 82.24% | 28.87% | ||
20-Day Relative Strength | 55.75% | 55.44% | 39.78% | ||
Weighted Alpha | -23.10 | +22.12 | -0.33 | ||
Today's Opinion | 40% Sell | 88% Buy | 88% Sell | ||
Previous Opinion | 64% Sell | 88% Buy | 88% Sell | ||
Last Month's Opinion | 64% Sell | 56% Buy | 24% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +4.86% since 11/09/20 | +3.15% since 04/22/24 | +1.60% since 04/22/24 | ||
Low | 15.10 on 11/10/20 | 70.78 on 04/24/24 | 23.68 on 04/25/24 | ||
High | 16.15 on 11/16/20 | 75.22 on 04/29/24 | 26.26 on 04/23/24 | ||
1-Month | |||||
%Chg | +0.92% since 10/16/20 | +1.46% since 03/28/24 | -17.63% since 03/28/24 | ||
Low | 14.00 on 10/29/20 | 70.71 on 04/19/24 | 23.68 on 04/25/24 | ||
High | 16.15 on 11/16/20 | 75.22 on 04/29/24 | 31.00 on 04/01/24 | ||
3-Month | |||||
%Chg | -2.07% since 08/14/20 | +6.25% since 01/29/24 | -32.69% since 01/29/24 | ||
Low | 14.00 on 10/29/20 | 69.23 on 01/30/24 | 23.68 on 04/25/24 | ||
High | 17.03 on 08/19/20 | 77.72 on 02/23/24 | 41.04 on 02/15/24 | ||
6-Month | |||||
%Chg | +4.58% since 05/15/20 | +14.40% since 10/27/23 | +4.21% since 10/27/23 | ||
Low | 14.00 on 10/29/20 | 63.72 on 11/03/23 | 23.68 on 04/25/24 | ||
High | 19.24 on 06/08/20 | 77.72 on 02/23/24 | 44.32 on 12/28/23 | ||
Key Statistics | |||||
Market Capitalization, $K | 8,586,212 | 12,440,756 | 4,374,700 | ||
Shares Outstanding, K | 541,546 | 166,878 | 175,832 | ||
Annual Sales | 11,500,500,000 | 2,992,000,000 | 9,300,000 | ||
Annual Net Income | 16,800,000 | 548,000,000 | -643,200,000 | ||
Last Quarter Sales | 2,972,100,000 | 865,780,000 | 1,750,000 | ||
Last Quarter Net Income | 185,700,000 | 165,470,000 | -168,150,000 | ||
60-Month Beta | 1.45 | 0.58 | 1.03 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.36 on 11/06/20 | 0.99 on 01/31/24 | -0.96 on 02/22/24 | ||
Latest Earnings Date | 11/06/20 | 05/07/24 | 05/02/24 | ||
Most Recent Dividend | 0.060 on 06/27/07 | 0.410 on 07/28/23 | N/A | ||
Next Ex-Dividends Date | N/A | 07/28/23 | N/A | ||
Ratios | |||||
Price/Earnings ttm | 3.29 | 19.53 | 0.00 |